Life Sciences
Accelerating Drug Discovery By AI-Driven Molecule Generation
AI molecule generation platform to speed up early-stage drug discovery in skin rejuvenation.
12x
Less drug candidates in HTS
37
Molecules confirmed active through wet lab validation
10x
Faster preclinical narrowing compared to baseline
Challenge
Identifying and prioritizing novel small molecules for skin rejuvenation using transcriptomic data and pathway analysis — in a scalable, efficient way to support early-phase drug development.
Outcomes We Deliver
Solution
Blackthorn AI delivered a pipeline that combined generative AI, pathway graphs, and omics data ingestion to power molecule generation. The system enabled fast iteration, integration of biological constraints, and reduced reliance on trial-and-error lab synthesis.
Tech Stack
To accelerate molecule discovery, Blackthorn AI used:
Roadmap
Project duration
Team Size
Delivering Impact
Beyond the values already highlighted, there’s even more to discover. Our commitment to innovation, client success, and impactful results sets us apart.